Showing results (201-210 of 224) with videos related to
Sort By:
Pageof 23
Nature Clinical Practice. Rheumatology|August 1, 2007
The changing epidemiology of goutEdward Roddy, Weiya Zhang, Michael DohertyNature Clinical Practice. Rheumatology|June 1, 2007
Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?Petros Efthimiou, Apostolos Kontzias, Carla M Ward, et al.Nature Clinical Practice. Rheumatology|May 2, 2007
Technology insight: tools for research, diagnosis and clinical assessment of treatment in idiopathic inflammatory myopathiesIngrid E Lundberg, Helene AlexandersonNature Clinical Practice. Rheumatology|November 27, 2007
Adipokines as emerging mediators of immune response and inflammationFrancisca Lago, Carlos Dieguez, Juan Gómez-Reino, et al.Nature Clinical Practice. Rheumatology|November 30, 2006
Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitidesCees G M Kallenberg, Peter Heeringa, Coen A StegemanNature Clinical Practice. Rheumatology|December 19, 2008
Is denosumab better than alendronate in the treatment of osteoporosis?E Michael LewieckiNature Clinical Practice. Rheumatology|December 23, 2008
The molecular basis of pain and its clinical implications in rheumatologyBrendan Bingham, Seena K Ajit, David R Blake, et al.Nature Clinical Practice. Rheumatology|December 23, 2008
There's more to life than everyday function: the challenge of measuring social role participation in ankylosing spondylitisAileen M Davis, Rosalind Wong, Elizabeth M Badley, et al.Nature Clinical Practice. Rheumatology|March 3, 2009
How do the efficacy and safety of abatacept and infliximab compare in the treatment of active RA?Peter C TaylorNature Clinical Practice. Rheumatology|March 3, 2009
Is tocilizumab in combination with traditional DMARDs safe and effective for patients with active RA?Eugen Feist, Gerd-R BurmesterPageof 23